Stock Analiz

HUTCHMED (China) Ltd (HCM) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

HUTCHMED (China)’s revenue went from $216M in fiscal 2016 to $549M in fiscal 2025, growth of about 10.9% a year.

Net income in fiscal 2025 was $457M, a net margin of 83.3%; the highest of the period.

Over the twelve months to June 30, 2026, revenue was $549M and net income $18M.

Free cash flow was -$79M in fiscal 2025 and positive in 1 of the 10 years shown.

Revenue, profit and cash flow by year

Revenue
2016: $216M162017: $241M172018: $214M182019: $205M192020: $228M202021: $356M212022: $426M222023: $838M232024: $630M242025: $549M25$549M
Net income
2016: $12M162017: -$27M172018: -$75M182019: -$106M192020: -$126M202021: -$195M212022: -$361M222023: $101M232024: $38M242025: $457M25$457M
Free cash flow
2016: -$14M162017: -$14M172018: -$39M182019: -$89M192020: -$70M202021: -$221M212022: -$305M222023: $187M232024: -$17M242025: -$79M25-$79M
EPS (diluted)
2016: $0.07162017: $-0.15172018: $-0.43182019: $-0.61192020: $-0.72202021: $-1.12212022: $-2.07222023: $0.58232024: $0.22242025: $2.6225$2.62

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$549M$549M$630M$838M$426M$356M$228M$205M$214M$241M$216M
Gross profit—$212M$281M$454M$115M————$71M$67M
Operating income—-$39M-$44M$18M-$408M-$328M-$197M-$146M-$93M-$53M-$47M
Net income$18M$457M$38M$101M-$361M-$195M-$126M-$106M-$75M-$27M$12M
EPS (diluted)$0.10$2.62$0.22$0.58$-2.07$-1.12$-0.72$-0.61$-0.43$-0.15$0.07
R&D—$148M$212M$302M$387M$299M$175M$138M$114M$76M$67M
Revenue growth—−13.0%−24.8%+96.5%+19.7%+56.2%+11.3%−4.3%−11.2%+11.6%+21.2%

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow$20M-$65M$497000$219M-$269M-$204M-$62M-$81M-$33M-$9M-$10M
Capital spending-$11M-$14M-$18M-$33M-$37M-$16M-$8M-$9M-$6M-$5M-$4M
Free cash flow$10M-$79M-$17M$187M-$305M-$221M-$70M-$89M-$39M-$14M-$14M
Dividends paid—$0$0$0$0$0$0$0$0$0$0
Buybacks——$36M$9M$48M$27M$13M$346000$5M$1M$604000
Stock-based pay———————————

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$1.4B$836M$886M$631M$1.0B$435M$217M$301M$358M$104M
Debt—$98M$90M$86M$27M$39M$36M$33M$33M$30M$47M
Equity—$1.2B$760M$731M$610M$987M$484M$288M$389M$462M$184M
Total assets—$1.8B$1.3B$1.3B$1.0B$1.4B$724M$465M$532M$598M$342M
Shares (diluted)175M174M174M174M174M174M174M174M174M174M174M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin—38.7%44.6%54.1%27.0%————29.6%31.0%
Operating margin—-7.1%-6.9%2.2%-95.6%-92.2%-86.3%-71.5%-43.3%-22.1%-21.6%
Net margin3.3%83.3%6.0%12.0%-84.6%-54.7%-55.1%-51.7%-34.9%-11.1%5.4%
FCF margin1.8%-14.4%-2.8%22.3%-71.6%-62.0%-30.7%-43.7%-18.3%-5.8%-6.4%
ROIC—-2.6%-4.1%2.1%-63.9%-25.3%-29.9%-36.0%-17.3%-8.6%-15.9%
ROE—36.9%5.0%13.8%-59.1%-19.7%-26.0%-36.8%-19.2%-5.8%6.3%

Frequently asked questions

What is HUTCHMED (China)’s annual revenue?

$549M in fiscal 2025 and $549M over the twelve months to June 30, 2026.

How much profit does HUTCHMED (China) make?

Net income was $457M in fiscal 2025 (net margin 83.3%).

Is HUTCHMED (China)’s revenue growing?

No: revenue fell 13.0% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.